androstane-3,17-diol has been researched along with estriol in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (40.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ruh, TS | 1 |
Blaustein, A; Levitz, M; Raju, U | 1 |
Bercovici, JP; Kerlan, V; Le Martelot, MT; Nahoul, K | 1 |
BĂ©langer, A; Guillemette, C; Hum, DW | 1 |
Burry, KA; Hermsmeyer, RK; Katzenellenbogen, BS; Katzenellenbogen, JA; Mishra, RG; Nealen, ML; Oparil, S; Stanczyk, FZ | 1 |
5 other study(ies) available for androstane-3,17-diol and estriol
Article | Year |
---|---|
Simultaneous separation of estrogens and androgens using thin-layer chromatography.
Topics: Androgens; Androstane-3,17-diol; Chromatography, Thin Layer; Dihydrotestosterone; Estradiol; Estriol; Estrogens; Estrone; Solvents; Testosterone | 1976 |
Conjugation of androgens and estrogens by human breast tumors in vitro.
Topics: Adult; Aged; Androgens; Androstane-3,17-diol; Androstenedione; Androsterone; Breast Neoplasms; Carcinoma; Carcinoma, Intraductal, Noninfiltrating; Estriol; Estrogens; Female; Humans; Middle Aged; Receptors, Estrogen; Testosterone | 1980 |
Longitudinal study of maternal plasma bioavailable testosterone and androstanediol glucuronide levels during pregnancy.
Topics: 17-alpha-Hydroxyprogesterone; Androstane-3,17-diol; Androstenedione; Estradiol; Estriol; Female; Humans; Hydroxyprogesterones; Longitudinal Studies; Pregnancy; Progesterone; Sex Hormone-Binding Globulin; Testosterone | 1994 |
Specificity of glucuronosyltransferase activity in the human cancer cell line LNCaP, evidence for the presence of at least two glucuronosyltransferase enzymes.
Topics: Adenocarcinoma; Androstane-3,17-diol; Androsterone; Binding, Competitive; Dihydrotestosterone; Estradiol; Estriol; Estrone; Glucuronosyltransferase; Humans; Kinetics; Male; Prostatic Neoplasms; Substrate Specificity; Testosterone; Tumor Cells, Cultured | 1995 |
Metabolite ligands of estrogen receptor-beta reduce primate coronary hyperreactivity.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Administration, Cutaneous; Androstane-3,17-diol; Animals; Calcium Signaling; Chrysenes; Coronary Vasospasm; Estriol; Estrogen Receptor beta; Female; Gene Expression; Genistein; Macaca mulatta; Muscle, Smooth, Vascular; Nitriles; Propionates; Receptors, Thromboxane; Serotonin; Vasoconstriction | 2006 |